While this form of leukemia is resistant to LSD1 inhibitors or LSD1 depletion, LSD1 inhibition sensitized APL cells to low physiological concentrations of ATRA, and cotreatment substantially enhanced survival in leukemic mice (57). This evidence concerns the gene KDM1A and acute promyelocytic leukemia.